Examining the Effectiveness of Asynchronous Versus Synchronous Yoga for Veterans With Chronic Pain
Launched by PORTLAND VA MEDICAL CENTER · May 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether pre-recorded yoga videos can help veterans with chronic pain just as much as live online yoga sessions. The researchers want to find out if these videos are a practical option for managing pain and if they can be used more widely. Over four months, participants will take part in a five-session virtual yoga course, continue practicing yoga on their own or in a VA class for 12 weeks, and complete some online assessments and a brief interview at the end.
To be eligible for the trial, participants must be U.S. veterans who are receiving care from a VA medical or mental health provider and have been diagnosed with musculoskeletal pain. They should have a moderate level of pain and be able to use video conferencing for the study. Other requirements include being able to move safely without assistance and meeting certain health guidelines. This study aims to provide valuable insights into how effective yoga can be for pain management, which could benefit many veterans in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • U.S. Veteran enrolled at VAPORHCS and has established care with a VA medical or mental health provider.
- • Diagnosed with musculoskeletal pain, confirmed by electronic health record review and phone screening.
- • Has an average pain severity of at least 4 in the past 3 months, assessed by items 1-5 of the Brief Pain Inventory, Short Form.
- • Aged 18 or over.
- • Capable of using video teleconferencing to complete enrollment, assessment, and video interventions.
- • Meets physical readiness, assessed by the Physical Activity Readiness Questionnaire (PAR-Q) and approved for yoga participation by their primary care team or physical therapy team.
- • Able to sit and stand from the floor without assistance
- • Able to ambulate community distances without an assistive device
- • Intact sensation in lower extremities below the knees
- Exclusion Criteria:
- • Unable to read and write in English.
- • Unable to freely give informed consent.
- • Recent (past 3 months) psychotic symptoms consistent with a diagnosis of schizophrenia, schizoaffective disorder, delusional disorder, or other psychotic disorder and unrelated to PTSD. Assessed by medical record review and provider team.
- • Practicing yoga regularly defined as weekly or biweekly practice of 60 or more minutes for 6 months or more.
- • Recent (past 3 months) history of suicidal gesture related to physical pain or active suicidal ideation (plan, intent, means).
- • Concurrently enrolled in another research protocol involving a pain focused intervention.
- • Upcoming surgery that would impact yoga practice.
- • Active alcohol/other substance abuse or dependence (unless actively engaged in treatment). Assessed via the The Tobacco, Alcohol, prescription medication and other Substance use Tool (TAPS). A cutoff of 2 will be used to rule out.
- • Joint replacement within the past 12 months.
About Portland Va Medical Center
The Portland VA Medical Center is a leading clinical research institution dedicated to advancing healthcare for veterans through innovative research and clinical trials. As part of the U.S. Department of Veterans Affairs, the center focuses on a wide array of medical disciplines, including mental health, rehabilitation, and chronic disease management. With a commitment to improving patient outcomes, the Portland VA Medical Center engages in rigorous scientific inquiry while prioritizing the well-being and needs of veteran populations. Its collaborative environment fosters partnerships with academic institutions and healthcare organizations, ensuring that research findings translate into effective treatments and improved quality of care for those who have served in the armed forces.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported